MyFibroScan
#1 Keyword Rankings
Today
Top 10 Rankings
Today
Top 30 Rankings
Today
Top 100 Rankings
Today
Description
FibroScan® is the non-invasive solution for comprehensive management of liver health.
Fibroscan® provides unique and patented biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 2500 peer-reviewed publications and 60+ international guidelines.
myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way :
The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting Fibroscan® examination results.
Scores enhance Fibroscan® liver disease assessment with biological markers.
Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions.
- Agile™3+ is an aid to identify NAFLD patients with advanced fibrosis by combining VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins.
- Agile™4 is an aid to early identify NAFLD patients with cirrhosis by combining VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin.
- Fast™ is an aid to identify at risk NASH patients defined as NASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (NAFLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast™.
Hide..
Show more..
Fibroscan® provides unique and patented biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 2500 peer-reviewed publications and 60+ international guidelines.
myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way :
The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting Fibroscan® examination results.
Scores enhance Fibroscan® liver disease assessment with biological markers.
Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions.
- Agile™3+ is an aid to identify NAFLD patients with advanced fibrosis by combining VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins.
- Agile™4 is an aid to early identify NAFLD patients with cirrhosis by combining VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin.
- Fast™ is an aid to identify at risk NASH patients defined as NASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (NAFLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast™.
Screenshots
User Rating
3.5 out of 5
8 ratings in United States
5 star
5
4 star
0
3 star
0
2 star
0
1 star
3
Ratings History
Reviews
Loading...
Reviews are loading, wait a sec..
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
255
|
|
Top Free
|
|
403
|
Keywords
Users may also like
| Name | Reviews | Recent release | |
|---|---|---|---|
ECCO IBD
The App for the IBD Community
|
0
|
1 month ago | |
NASPGHAN Toolbox
|
2
|
5 years ago | |
COVID-19 iChart
COVID-19 drug interactions
|
1
|
1 year ago | |
ESC CVD Risk Calculation
For healthcare professionals
|
0
|
11 months ago | |
GI Guidelines
|
2
|
1 year ago | |
ESPEN Guidelines
|
0
|
1 year ago | |
Hepatology 2020
A clinical textbook
|
0
|
4 years ago | |
HEPAmet
|
0
|
5 years ago | |
GHAPP ACE
|
0
|
2 years ago |
Show More
Revenue and Downloads
Gain valuable insights into MyFibroScan performance with our analytics. Sign up now
to
access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- ECHOSENS
- Languages
- English
- Recent version
- 2.4.0 (3 months ago )
- Released on
- Apr 16, 2017 (7 years ago )
- Also available in
- United States, Taiwan, Russia, Mexico, Argentina, United Kingdom, Hungary, Netherlands, Chile, Brazil, Japan, Malaysia, Lebanon, Nigeria, South Africa, Norway, New Zealand, Kazakhstan, Peru, Philippines, Pakistan, Poland, Portugal, Romania, Saudi Arabia, Sweden, Singapore, Thailand, Turkey, United Arab Emirates, Algeria, Austria, Australia, Azerbaijan, Belgium, Belarus, Canada, Switzerland, Colombia, Czechia, Dominican Republic, Kuwait, Ecuador, Egypt, Greece, Hong Kong, Indonesia, Ireland, Israel, India, Italy, Denmark, Finland
- Last updated
- 1 month ago